Search results for "ionizing radiations"

showing 3 items of 3 documents

Radioprotection and Radiomitigation: From the Bench to Clinical Practice.

2020

The development of protective agents against harmful radiations has been a subject of investigation for decades. However, effective (ideal) radioprotectors and radiomitigators remain an unsolved problem. Because ionizing radiation-induced cellular damage is primarily attributed to free radicals, radical scavengers are promising as potential radioprotectors. Early development of such agents focused on thiol synthetic compounds, e.g., amifostine (2-(3-aminopropylamino) ethylsulfanylphosphonic acid), approved as a radioprotector by the Food and Drug Administration (FDA, USA) but for limited clinical indications and not for nonclinical uses. To date, no new chemical entity has been approved by …

0301 basic medicineMedicine (miscellaneous)free radicalsReviewPharmacologyFilgrastimGeneral Biochemistry Genetics and Molecular BiologyIonizing radiation03 medical and health sciences0302 clinical medicineSargramostimNew chemical entitymedicinelcsh:QH301-705.5business.industryradioprotectorsAcute Radiation SyndromeAmifostine030104 developmental biologyantioxidantslcsh:Biology (General)Protective Agents030220 oncology & carcinogenesisradiomitigatorsionizing radiationsbusinessPegfilgrastimmedicine.drugBiomedicines
researchProduct

Nose-to-brain delivery of insulin enhanced by a nanogel carrier.

2018

Recent evidences suggest that insulin delivery to the brain can be an important pharmacological therapy for some neurodegenerative pathologies, including Alzheimer disease (AD). Due to the presence of the Blood Brain Barrier, a suitable carrier and an appropriate route of administration are required to increase the efficacy and safety of the treatment. Here, poly(N-vinyl pyrrolidone)-based nanogels (NG), synthetized by e-beam irradiation, alone and with covalently attached insulin (NG-In) were characterized for biocompatibility and brain delivery features in a mouse model. Preliminarily, the biodistribution of the "empty" nanocarrier after intraperitoneal (i.p.) injection was investigated b…

Male0301 basic medicineIonizing radiationBiodistributionmedicine.medical_treatmentPharmaceutical SciencePharmacologyBrain delivery; Insulin; Intranasal inoculation; Ionizing radiations; Nanogel; Nanogel biocompatibility and clearanceBlood–brain barrierNanogel biocompatibility and clearance03 medical and health sciencesRoute of administrationNanogel0302 clinical medicinemedicineAnimalsHypoglycemic AgentsInsulinProtein kinase BAdministration IntranasalBrain deliveryDrug CarriersChemistryInsulinBrainPovidoneIntranasal inoculationMice Inbred C57BLNasal Mucosa030104 developmental biologymedicine.anatomical_structureAcrylatesNasal administrationSettore CHIM/07 - Fondamenti Chimici Delle TecnologieNanocarriersGels030217 neurology & neurosurgeryNanogel Ionizing radiationNanogel
researchProduct

Cell and molecular response to IORT treatment

2014

Ionizing radiations (IRs) generated by intraoperative radiotherapy (IORT) treatment activates both pro- and antiproliferative signal pathways producing an imbalance in cell fate decision regulated by several genes and factors involved in cell cycle progression, survival and/or cell death, DNA repair and inflammation. This paper describes the latest advances on cellular and molecular response to IR, highlighting the most relevant research data from cell biology, gene expression profiling and epigenetic studies on different tumor cell types. Understanding the cell molecular strategies to choose between death and survival, after an irradiation-induced damage, opens new avenues for the selectio…

ionizing radiations (IRs)cell deathIntraoperative radiotherapy (IORT)gene expression profile
researchProduct